Your browser doesn't support javascript.
Vildagliptin enhances differentiation of insulin producing cells from adipose-derived mesenchymal stem cells
Cell Journal [Yakhteh]. 2019; 20 (4): 477-482
in English | IMEMR (Eastern Mediterranean) | ID: emr-199616
Responsible library: EMRO
ABSTRACT

OBJECTIVE:

Type 1 diabetes is caused by destruction of beta cells of pancreas. Vildagliptin [VG], a dipeptidyl peptidase IV [DPP IV] inhibitor, is an anti-diabetic drug, which increases beta cell mass. In the present study, the effects of VG on generation of insulin-producing cells [IPCs] from adipose-derived mesenchymal stem cells [ASCs] is investigated

Similar

MEDLINE

...
LILACS

LIS

Index: IMEMR (Eastern Mediterranean) Language: English Journal: Cell J. [Yakhteh] Year: 2019